Cargando…
Drug regimens identified and optimized by output-driven platform markedly reduce tuberculosis treatment time
The current drug regimens for treating tuberculosis are lengthy and onerous, and hence complicated by poor adherence leading to drug resistance and disease relapse. Previously, using an output-driven optimization platform and an in vitro macrophage model of Mycobacterium tuberculosis infection, we i...
Autores principales: | Lee, Bai-Yu, Clemens, Daniel L., Silva, Aleidy, Dillon, Barbara Jane, Masleša-Galić, Saša, Nava, Susana, Ding, Xianting, Ho, Chih-Ming, Horwitz, Marcus A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5287291/ https://www.ncbi.nlm.nih.gov/pubmed/28117835 http://dx.doi.org/10.1038/ncomms14183 |
Ejemplares similares
-
Artificial intelligence enabled parabolic response surface platform identifies ultra-rapid near-universal TB drug treatment regimens comprising approved drugs
por: Clemens, Daniel L., et al.
Publicado: (2019) -
Ultra-rapid near universal TB drug regimen identified via parabolic response surface platform cures mice of both conventional and high susceptibility
por: Lee, Bai-Yu, et al.
Publicado: (2018) -
Listeria-vectored multi-antigenic tuberculosis vaccine protects C57BL/6 and BALB/c mice and guinea pigs against Mycobacterium tuberculosis challenge
por: Jia, Qingmei, et al.
Publicado: (2022) -
Listeria-Vectored Multiantigenic Tuberculosis Vaccine Enhances Protective Immunity against Aerosol Challenge with Virulent Mycobacterium tuberculosis in BCG-Immunized C57BL/6 and BALB/c Mice
por: Jia, Qingmei, et al.
Publicado: (2022) -
Single vector platform vaccine protects against lethal respiratory challenge with Tier 1 select agents of anthrax, plague, and tularemia
por: Jia, Qingmei, et al.
Publicado: (2018)